Therorna completes Series A financing to accelerate pipeline development and clinical transformation of circRNA-based platform

/PRNewswire/ -- Therorna Inc., a China-based biotech company specialized in the development of cutting-edge circular RNA (or circRNA) technology-based new...

Related Keywords

China ,Beijing ,Boston ,Massachusetts ,United States ,Shanghai ,Hong Kong ,Singapore ,Chinese ,Yu Zeng ,Daniel Tang ,Minchuan Wang ,Wensheng Wei ,Changzu Cai ,H Health ,H Health Investment ,Therorna Inc ,Wei Lab ,Sherpa Healthcare Partners ,Health Investment ,Quan Capital ,Cenova Capital ,Professor Wensheng Wei ,Chief Executive Officer ,Professor Wei ,Healthcare Partners ,Managing Director ,Echo Zhang ,Middle East ,North Africa ,Menlo Park ,